Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2054412

CC(Nc1ncnc2[nH]cnc12)c1cc(Cl)c2cccnc2c1N1CCN(C(=O)C2CCC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.40
SOS1 Q07889 6/20 0.37
L3MBTL1 Q9Y468 2/20 0.34
IDE P14735 1/20 0.34
BTK Q06187 1/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
ALOX12 P18054 2/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
MC4R P32245 1/20 0.33
POLB P06746 1/20 0.33
LRRK2 Q5S007 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2052514 0.97 PIK3CD (0.41) PIK3CDSOS1L3MBTL1BTKNPC1
SCHEMBL2013364 0.95 PIK3CD (0.42) PIK3CDSOS1L3MBTL1IDEBTK
Trifluoroacetic Acid SCHEMBL2052365 0.94 PIK3CD (0.39) PIK3CDSOS1L3MBTL1BTKNPC1
SCHEMBL2165010 0.92 PIK3CD (0.42) PIK3CDSOS1L3MBTL1BTKNPC1
Trifluoroacetic Acid SCHEMBL2053550 0.90 PIK3CD (0.41) PIK3CDL3MBTL1BTKNPC1RAB9A
Trifluoroacetic Acid SCHEMBL2054109 0.90 PIK3CD (0.43) PIK3CDL3MBTL1NPC1RAB9AALOX12
SCHEMBL2016097 0.89 PIK3CD (0.40) PIK3CDSOS1L3MBTL1BTKNPC1
Trifluoroacetic Acid SCHEMBL2164857 0.89 PIK3CD (0.42) PIK3CDSOS1L3MBTL1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL2036109 0.89 PIK3CD (0.42) PIK3CDSOS1L3MBTL1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL2163475 0.89 PIK3CD (0.42) PIK3CDSOS1L3MBTL1BTKNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680108-B2 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2014-03-25 US disclosed
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION 2011-07-28 US disclosed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183985-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS PIK3R1, PIK3R3, PIK3R2 PIK3CD 13/4885SOS1 2308/4885L3MBTL1 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.